You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Claims for Patent: 6,806,399


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,806,399
Title: Pollen-mediated method for transformation of maize, tomato or melon
Abstract:A genotype-independent method for efficiently carrying out pollen-mediated transformation of maize, tomato or melon is described. The method uses pollen pretreated with silicon carbide and DNA to produce transformed plants with high efficiency and reproducibility.
Inventor(s): Korol; Abraham (Haifa, IL), Fahima; Tzion (Haifa, IL), Nevo; Eviator (Haifa, IL)
Assignee: Carmel-Haifa University Economic Corporation Ltd. (Haifa, IL)
Application Number:09/552,147
Patent Claims:1. A method for genetic transformation of tomato or melon, said method comprising the steps of: (a) preparing a silicon carbide fibers solution; (b) preparing a pollen germination medium; (c) preparing a DNA solution; (d) mixing said silicon carbide fiber solution with said pollen germination medium and said DNA solution to form a mixture; (e) adding fresh pollen into said mixture to form a paste; (f) vortexing said paste for 30-60 seconds, thereby producing a vortexed paste; (g) applying said vortexed paste on female reproduction plant parts of melon or tomato plants for pollination; and (h) selecting transformants.

2. The method of claim 1, wherein the silicon carbide fibers of said silicon carbide fiber solution are approximately 0.1-20 .mu.m diameter and 1-250 .mu.m length.

3. The method of claim 2, wherein said silicon carbide fibers are between 1-2 .mu.m in diameter and 10-180 .mu.m in length.

4. The method of claim 1, wherein the silicon carbide fiber solution comprises a sufficient amount of sterile water or solvent, to make a 5% to 25% aqueous solution.

5. The method of claim 1, wherein said pollen germination medium is a solution containing about 5%-15% sucrose, 0.01%-1.0% H.sub.3 BO.sub.3, 0.01% to 1.0% Ca(NO.sub.3).sub.2 4H.sub.2 O at pH 5.6.

6. The method of claim 5, wherein the pollen germination medium contains about 15% sucrose, 0.018% H.sub.3 BO.sub.3, 0.04% Ca(NO.sub.3).sub.2 4H.sub.2 O at pH 5.6.

7. The method of claim 1, wherein said DNA solution is a solution of plasmid DNA.

8. The method of claim 7, wherein said plasmid DNA is dissolved in a Tris EDTA solution.

9. The method of claim 1, wherein selection of transformants is based on the phenotypic expression of a selectable marker gene, wherein the gene confers antibiotic resistance or herbicide resistance on the transformants or affects anthocyanin coloration of the transformants.

10. The method of claim 9, wherein said selectable marker gene with a phenotypic expression is a gene regulating anthocyanin levels.

11. The method of claim 9, wherein said selectable marker gene is a gene providing resistance to at least one antibiotic.

12. The method of claim 9, wherein said selectable marker gene encodes neomycin phosphotransferase.

13. The method of claim 9, wherein said selectable marker gene is a gene providing resistance to kanamycin.

14. The method of claim 9, wherein said selectable marker gene encodes phosphinothricin acetyltransferase.

15. A method for genetic transformation of sexually reproducing maize, said method comprising the steps of: (a) preparing a silicon carbide fiber solution; (b) preparing a pollen germination medium; (c) preparing a DNA solution; (d) mixing said silicon carbide fiber solution with said pollen germination medium and said DNA solution to form a mixture; (e) adding fresh pollen into said mixture to form a paste; (f) vortexing said paste for 30 to 60 seconds, thereby producing a vortexed paste; (g) applying said vortexed paste on silks of maize plants for pollination; and (h) selecting transformants.

16. The method of claim 15, wherein the silicon carbide fibers of said silicon carbide fiber solution are approximately 0.1-20 .mu.m in diameter and 1-250 .mu.in length.

17. The method of claim 16, wherein said silicon carbide fibers are between 1-2 .mu.m in diameter and 10-180 .mu.m in length.

18. The method of claim 15, wherein the silicon carbide fiber solution comprises a sufficient amount of sterile water or solvent, to make a 5% to 25% aqueous solution.

19. The method of claim 15, wherein the pollen germination medium contains about 5%-15% sucrose, 0.01%-1.0% H.sub.3 BO.sub.3, 0.01% to 1.0% Ca(NO.sub.3).sub.2 4H.sub.2 O at pH.

20. The method of claim 19, wherein the pollen germination medium contains about 15% sucrose, 0.018% H.sub.3 BO.sub.3, 0.04% Ca(NO.sub.3).sub.2 4H.sub.2 O at pH 5.6.

21. The method of claim 15, wherein said DNA solution is a solution of plasmid DNA.

22. The method of claim 21, wherein said solution of plasmid DNA is dissolved in a Tris EDTA solution.

23. The method of claim 15, wherein selection of transformants is based on the phenotypic expression of a selectable marker gene, wherein the gene confers antibiotic resistance or herbicide resistance on the transformants or affects anthocyanin coloration of the transformants.

24. The method of claim 23, wherein said selectable marker gene is a gene providing resistance to neomycin phosphotransferase.

25. The method of claim 23, wherein said selectable marker gene is a gene providing resistance to kanamycin.

26. The method of claim 23, wherein said selectable marker gene encodes phosphinothricin acetyltransferase.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.